CORE HEALTHCARE LTD.

NSE : NABSE : 500091ISIN CODE : INE494A01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE6.870 (0 %)
PREV CLOSE ( ) 6.87
OPEN PRICE ( ) 6.67
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )6.67 7.30
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2006Mar2005Mar2004Mar2003Mar2002
Profit Before Tax-618.12-1571.81-1523.41-1451.330.00
Adjustment443.241654.531699.741615.180.00
Changes In working Capital183.11-78.79-112.27-35.05NA
Cash Flow after changes in Working Capital8.233.9464.06128.800.00
Cash Flow from Operating Activities-1.08-963.62-1109.47-459.67NA
Cash Flow from Investing Activities-4.54-164.93-123.05-190.65NA
Cash Flow from Financing Activities-7.391106.771244.89657.46NA
Net Cash Inflow / Outflow-13.01-21.7712.377.130.00
Opening Cash & Cash Equivalents34.4256.1943.8236.69NA
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent21.4134.4256.1943.82NA

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.